Rolling e-learning: an educational model to support Italian healthcare professionals during the COVID-19 pandemic
Keywords:
e-learning, Continuing medical education (CME), Education in epidemics and pandemics, COVID-19, SARS-CoV-2Abstract
Background and aim: Rolling reviews have been widely used by the scientific community during the COVID-19 pandemic to provide guidelines and identify potential treatments in such a quickly evolving emergency. Throughout the two pandemic years, we provided independent and continuously updated (rolling) e-learning courses on COVID-19 targeted to Italian healthcare professionals with the aim of increasing dissemination based on the emerging evidence. The results of this project are presented in this brief report.
Methods: We launched five main courses on COVID-19 – with focus on treatments and vaccines – from February 2020 to December 2022. For each course, we collected and analised participation data and, via questionnaires, customer-satisfaction data on relevance, quality, efficacy and sponsor perception.
Results: From 22 February 2020 to 31 December 2022, a total of 224,459 enrollments were registered over the five courses with 192,966 passes (86%), for which Continuing Medical Education (CME) credits were awarded. Over 94% of participants considered the contents of high quality, relevant and effective for their educational needs. The absence of sponsorship perception, 83% overall, decreased relevantly for the two courses on COVID-19 vaccines (68.3%).
Conclusions: Italian healthcare professionals working during the pandemic overwhelmingly appreciated and valued the rolling e-learning offer aimed at widening the dissemination of the best practices on COVID-19. This educational model provides independent, evidence-based and tailored information with the undoubted advantages of time flexibility, remote participation and continuous update, all elements that make it a useful tool in a pandemic as well as in a post-pandemic era.
References
Fordis M, King JE, Ballantyne CM, et al. Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trial. JAMA. 2005;294(9):1043-1051. doi:10.1001
/jama.294.9.1043.
Cook DA, Levinson AJ, Garside S, Dupras DM, Erwin PJ, Montori VM. Internet-based learning in the health professions: a meta-analysis. JAMA. 2008;300(10):1181-1196. doi:10.1001/jama.300.10.1181.
Cervero RM, Gaines JK. The impact of CME on physician performance and patient health outcomes: an updated synthesis of systematic reviews. J Contin Educ Health Prof. 2015;35(2):131-138. doi:10.1002/chp.21290.
TELL ME project. Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence (2013-2015). Accessed 22 January 2023. https://www.tellmeproject.eu/
World Health Organization (WHO). E-learning platform OpenWHO. Accessed 22 January 2023. https://openwho
.org
European Centre for Disease Prevention and Control (ECDC). Training programmes. Accessed 22 January 2023. https://www.ecdc.europa.eu/en/training
Italian National Institute of Health (ISS). EDUISS, piattaforma per la Formazione a Distanza (FAD) [e-learning platform EDUISS. in Ita-lian]. Accessed 22 January 2023. https://www.eduiss.it/
Pregliasco F, Valetto MR, Stella R, Scarpa N, Dri P. E-learning course on COVID-19: an example of educational preparedness and quick response. Rapid response to: Paterlini M. On the front lines of coronavirus: the Italian response to covid-19. BMJ. 2020;368:m1065. Pub-lished 16 March 2020. doi:10.1136/bmj.m1065.
Pregliasco F, Valetto MR, Anelli F, Mandelli A, Scarpa N, Dri P. Rolling e-learning courses on COVID-19: an Italian experience. Research Square. Preprint (Version 2), 22 March 2022. doi:10.21203/rs.3.rs-1321853/v2.
Italian National Federation of the Associations of Doctors, Surgeons and Dentists (FNOMCeO) and National Federation of Orders for Nursing Professions (FNOPI). FadInMed, piattaforma per la Formazione a Distanza (FAD) per medici, odontoiatri e infermieri. [FadInMEd, e-learning platform for physicians, dentists, and nurses. In Italian]. -Accessed 22 January 2023. https://www.fadinmed.it/
Saepe. La piattaforma indipendente per la formazione continua [e-learning independent platform for continuing medical education. In Italian]. Accessed 22 January 2023. https://www.saepe.it/
Formars. La piattaforma per la formazione continua della popolazione [e-learning platform for the general population. In Italian]. Accessed 22 January 2023. https://www
.formars.it
Agenzia Nazionale per i Servizi Sanitari Regionali Commissione Nazionale per La Formazione Continua
(Age.Na.S.) Manuale sulla formazione continua del professionista sanitario [Handbook on continuing medical education of health profes-sionals. In Italian]. Accessed 22 January 2023. https://ape.agenas.it/documenti
/normativa/Manuale_formazione_continua_professionista
_sanitario/Manuale_sulla_formazione_continua_professionista
_sanitario.pdf
Italian Ministry of Health. COVID-19, e-learning for physicians [Covid-19, formazione a distanza per i medici]. Published 15 March 2020. Accessed 22 January 2023.
https://www.salute.gov.it/portale/nuovocoronavirus
/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano
&menu=notizie&p=dalministero&id=4238
Covid-19 Response - EUnetHTA. Published 29 June 2020. Accessed 22 January 2023. https://eunethta.eu/services
/covid-19/
Cochrane Collaboration. Cochrane identifies its priority areas for future COVID-19 work and lists other critical questions for the research community. www.cochrane.org. Accessed 22 January 2023. https://www.cochrane.org
/news/cochrane-identifies-its-priority-areas-future-covid
-19-work-and-lists-other-critical-questions
World Health Organization (WHO). Living guidance for clinical management of COVID-19, 23 November 2021. https://www.who.int/publications/i/item/WHO-2019
-nCoV-clinical-2021-2
World Health Organization (WHO). WHO COVID-19 Solidarity Therapeutics Trial. Accessed 22 January 2023. https://www.who.int/emergencies/diseases/novel
-coronavirus-2019/global-research-on-novel-coronavirus
-2019-ncov/solidarity-clinical-trial-for-covid-19
-treatments
University of Oxford. RECOVERY Trial, Randomized Evaluation of COVID Therapy. Accessed 22 January 2023. https://www.recoverytrial.net
European Medicines Agency (EMA). Guidance for medicine developers and other stakeholders on COVID-19. Accessed 22 January 2023. https://www.ema.europa.eu
/en/human-regulatory/overview/public-health-threats
/coronavirus-disease-covid-19/guidance-medicine-developers
-other-stakeholders-covid-19
European Medicines Agency (EMA). Treatments and vaccines for COVID-19. Accessed 22 January 2023. https://www.ema.europa.eu/en/human-regulatory/overview
/public-health-threats/coronavirus-disease-covid-19
/treatments-vaccines-covid-19
U.S. Food and Drug Administration (FDA). Center for Drug Evaluation and Research. Coronavirus Treatment Acceleration Program (CTAP). Accessed 22 January 2023. https://www.fda.gov/drugs/coronavirus-covid-19-drugs
/coronavirus-treatment-acceleration-program-ctap
American Medical Association (AMA). AMA Code of Medical Ethics. 9.2.7 Financial Relationships with Industry in Continuing Medi-cal Education. Accessed 22 -January 2023. https://code-medical-ethics.ama-assn.org/sites/default
/files/2022-08/9.2.7.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Fabrizio Ernesto Pregliasco, Maria Rosa Valetto, Filippo Anelli, Ugo Moretti, Nicoletta Scarpa, Pietro Dri
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
